Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIOMEC trial
2023-505991-31-00Phase 3Completed
- Sponsor
- Karolinska University Hospital
- Start
- Sep 2023
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of paclitaxel and carboplatin in endometrial cancer (EC) (2 arms), sponsored by Karolinska University Hospital. Primary endpoint: Overall survival. Started Sep 2023; status: completed.
02
Drugs
paclitaxelcarboplatin
03
Conditions
endometrial cancer (EC)
Beyond the preview
Go deeper on 2023-505991-31-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-505991-31-00.